INNOVATION AND BEYOND

Dynamic megaceutics is a pre-clinical research laboratory with 100 % accuracy in delivering the result datas with human end points through anatomical and pathophysiological or biomarker level of human diseases. Our test models undergo various assesments which includes phenotype, cytology, biochemistry and expression profiles.

INNOVATION AND BEYOND

Dynamic megaceutics is a pre-clinical research laboratory with 100 % accuracy in delivering the result datas with human end points through anatomical and pathophysiological or biomarker level of human diseases. Our test models undergo various assesments which includes phenotype, cytology, biochemistry and expression profiles.

WHO ARE WE?

Dynamic megaceutics is a research laboratory that focuses on the modelling of human disease on zebrafish to replicate the anatomical and pathophysiological or biomarker levels of human disease. Our models can reproduce the end points of humans in a short period of time frame with the objective of providing accurate results.

ZEBRAFISH STUDY FOR HUMANS

We create our own cell culture for modelling and analyze the compound activity with human end points and the compound undergoes network pharmacology studies. We precisely resolve candidate activity, through our experience of monitoring various compounds in zebrafish models that mimic human pathophysiology and anatomical level along with the help of network pharmacology.

WHAT WE DO?

Dynamic Megaceutics

Zebrafish Modelling

The zebrafish which are in good condition are selected and a chemical mutagen is used to induce random point mutation and genotype screens are performed in the progeny to identify the progeny fish carrying a point mutation in gene associated with the desired disease and then the phenotypic screens are performed to further identify the model organism that meets human end points regarding the diseases.

Network Pharmacology

Network Pharmacology approaches can serve as a valuable tool for evidence-based Ayurveda to understand the medicines putative actions, indications, and mechanisms. A major portion of the network pharmacology is network analysis which mainly covers attribute analysis, topological analysis, network structure and stability, flow (flux) balance analysis and network models.

Bioinformatics
Molecular Dynamics

Molecular Dynamics

A molecular dynamics simulation is a physics-based approach for understanding atom level motion and interactions of bio-molecules using Newton’s physics. Molecular dynamics simulation helps to analyze molecular interactions between bio-molecules in a dynamic environment, to be much more accurate and mimics the interactions as would happen in a cellular atmosphere.

WHAT WE DO?

Zebrafish Modelling
Zebrafish

The zebrafish which are in good condition are selected and a chemical mutagen is used to induce random point mutation and genotype screens are performed in the progeny to identify the progeny fish carrying a point mutation in gene associated with the desired disease and then the phenotypic screens are performed to further identify the model organism that meets human end points regarding the diseases.

Network Pharmacology
Dynamic Megaceutics

Network Pharmacology approaches can serve as a valuable tool for evidence-based Ayurveda to understand the medicines putative actions, indications, and mechanisms. A major portion of the network pharmacology is network analysis which mainly covers attribute analysis, topological analysis, network structure and stability, flow (flux) balance analysis and network models.

Molecular Dynamics
Molecular Dynamics

A molecular dynamics simulation is a physics-based approach for understanding atom level motion and interactions of bio-molecules using Newton’s physics. Molecular dynamics simulation helps to analyze molecular interactions between bio-molecules in a dynamic environment, to be much more accurate and mimics the interactions as would happen in a cellular atmosphere.

OUR REPUTATION

It has been a pleasure to be a part of the research team. Looking forward to their path-breaking Innovatives in human disease models and therapeutics.
Vincent Albert MSc,
University of Gießen , Germany
It was great pleasure working with you guys, the nanotoxicity profiling using danio rerio model yielded results with images quality that can be published in peer review journal, satisfied with the work. Looking forward for more.
Siva Prasad M.Tech.,
Editor-Peer Review Management Spi Global & Independent Researcher
It has been nice knowing you. Your research looks promising and has promising future. Looking forward to work with you on more projects.
Ashwin Sridhar MSc,
National University of Singapore
The whole concept using animal models rather than cell culture model for therapeutics and understanding disease mechanism is more promising and exciting. I hope to see great contributions from you to the scientific community very soon.
Chandru PhD
Max Planck Institute for Biochemistry

SIGN UP TO OUR NEWSLETTER